XML 37 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8

Summary of Significant Accounting Policies Summary of Significant Accounting Policies (Narrative) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended	6 Months Ended	12 Months Ended
	Dec. 31, 2013 Cvs Caremark Corporation Member	Dec. 31, 2013 Pharmaceutical Walgreens Co Member	Jun. 30, 2013 Pharmaceutical Walgreens Co Member
Concentration Risk [Line Items]
Contract expiration date	Jun. 30, 2019	Aug. 31, 2013
Revenue, Major Customer, Percentage			20.00%
Expected JV Operational Date	Jul. 01, 2014
Term of Agreement	10 years
Quarterly joint venture payment	$ 25
Number of Years of Contract	3 years

X

- Definition

Contract expiration date

+ References

No definition available.

+ Details

Name:	cah_ContractExpirationDate
Namespace Prefix:	cah_
Data Type:	xbrli:dateItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The earliest date of which the U.S.-based generic sourcing entity (Sourcing JV) with CVS is expected to be operational.

+ References

No definition available.

+ Details

Name:	cah_ExpectedJVOperationalDate
Namespace Prefix:	cah_
Data Type:	xbrli:dateItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The number of years the contract has been extended.

+ References

No definition available.

+ Details

Name:	cah_NumberofYearsofContract
Namespace Prefix:	cah_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

An expected quarterly payment over the term of the Sourcing JV that the company will pay to CVS. To begin upon completion of final documentation and customary closing conditions.

+ References

No definition available.

+ Details

Name:	cah_Quarterlyjointventurepayment
Namespace Prefix:	cah_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Initial term of the agreement for the U.S.-based generic sourcing entity (Sourcing JV) with CVS.

+ References

No definition available.

+ Details

Name:	cah_TermofAgreement
Namespace Prefix:	cah_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_ConcentrationRiskLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13537-108611



Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6404-108592



Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13531-108611



Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 18

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6351-108592

+ Details

Name:	us-gaap_ConcentrationRiskPercentage1
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration